Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control: A randomized, double-blind, placebo-control...

por DeFronzo, Ralph A., Fleck, Penny R., Wilson, Craig A., Mekki, Qais
Publicado 2008

Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes

por Rosenstock, Julio, Inzucchi, Silvio E., Seufert, Jochen, Fleck, Penny R., Wilson, Craig A., Mekki, Qais
Publicado 2010

Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE t...

por Heller, Simon R., Bergenstal, Richard M., White, William B., Kupfer, Stuart, Bakris, George L., Cushman, William C., Mehta, Cyrus R., Nissen, Steven E., Wilson, Craig A., Zannad, Faiez, Liu, Yuyin, Gourlie, Noah M., Cannon, Christopher P.
Publicado 2017